Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells

Figure 3

PHA665752 inhibits HGF-induced migration through blockade of MAPK pathway. (A) SH-EP cells were pretreated for 60 minutes with PHA665752, PD98059 or LY294002 as shown, washed, and analyzed by transwell chemotaxis assay in presence of HGF (200 ng/mL). (B, C) SH-EP cells were pretreated with inhibitors for 60 minutes, followed by addition of HGF (200 ng/mL for 15 mins) and immunoblotting of cell lysates. (in Figure 3C, # indicates incubation with vitronectin alone without HGF; + indicates addition of HGF). Data represent mean +/- SD for triplicate independent experiments.

Back to article page